The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1218
September 28, 2005
View Complete Issue         Table of Contents 2019 
BiDil for Heart Failure
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
BiDil for Heart Failure
September 28, 2005 (Issue: 1218)
BiDil (NitroMed), a fixed-dose combination of isosorbide dinitrate and hydralazine, was approved by the FDA for adjunctive use in the treatment of heart failure in black patients.Both drugs are oral vasodilators that have been used together off-label...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: BiDil for Heart Failure
Article code: 1218a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.